In conjunction with the launch of a fourth wave of Corona virus, namely the "Delta Plus Mutant," which has been described as "the fiercest," given its rapid spread and targeting of new age groups, primarily children, the Egyptian Ministry of Health recently adopted a new protocol to treat Corona virus patients.

According to the Egyptian Minister of Health, Hala Zayed, the update of the Corona treatment protocol in its fifth version included the inclusion of monoclonal Ante Badiz, which achieved recovery rates of 95 percent with severe and medium cases.

The Protocol aims to ensure that Corona patients do not reach critical stages, reduce their hospitalization and provide effective results in mitigating HIV symptoms; Would the new protocol help reduce the risk of Delta Plus mutants?

It was found that "the aim of the Ministry of Health's inclusion of that drug in the Corona treatment protocol is to reduce mortality rates, due to Corona virus infection," in confirming that "the new drug is fast-acting and consists of a single dose, received by the patient in hospital within the first 10 days of infection with the new Corona virus."